Jennifer Michaelson - Feb 25, 2025 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Chief Scientific Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Feb 25, 2025
Transactions value $
-$32,039
Form type
4
Date filed
2/27/2025, 05:00 PM
Previous filing
Feb 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$32K -3.76K -2.58% $8.53 142K Feb 25, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.